A small but significant integration went live this week between two companies that don’t typically share a stage: Garmin, the GPS and fitness wearable giant, and Natural Cycles, the first and only FDA and CE-cleared birth control app. The result is a direct pipeline of body temperature data from wrist to algorithm, eliminating one of the most persistent friction points in fertility awareness methods.
Here’s what happened. Natural Cycles announced that users wearing compatible Garmin devices can now sync their overnight skin temperature data directly into the Natural Cycles app. No more waking up at the same time every morning to take a basal body temperature reading with a dedicated thermometer. No more fumbling for the device on the nightstand before getting out of bed, before drinking water, before doing anything that might skew the number. The watch handles it passively, while you sleep.
As Lifehacker reported, the integration works with Garmin watches that already track body temperature continuously — models in the Venu, Fenix, and Lily lines, among others. The temperature data flows from Garmin Connect into Natural Cycles, where the app’s algorithm interprets nightly readings to determine fertile and non-fertile days. Green days mean low probability of pregnancy. Red days mean high probability. The underlying science hasn’t changed; what’s changed is the data collection method.
That distinction matters more than it might seem.
Natural Cycles has been FDA-cleared as a digital contraceptive since 2018 — the first app to earn that designation. Its algorithm relies on the well-established physiological principle that a woman’s basal body temperature rises slightly after ovulation, typically by about 0.2 to 0.5 degrees Fahrenheit, due to increased progesterone. By tracking this thermal shift over time, the app builds a predictive model of each user’s cycle. But the method has always had a practical weakness: the thermometer. Traditional basal body temperature tracking requires an oral reading taken at roughly the same time every morning, immediately upon waking. Inconsistency introduces noise. Noise degrades accuracy.
Wearable temperature sensors change that equation. They collect data continuously throughout the night, producing a more complete thermal profile that’s less susceptible to the variables that plague single-point morning readings — a restless night, a different wake-up time, alcohol consumption the evening before. Natural Cycles had already integrated with the Oura Ring for similar reasons. The Garmin partnership extends this passive-collection model to a device category — the wrist-worn smartwatch — that has far broader market penetration.
And that’s the real commercial story here. Oura has roughly 2.5 million users. Garmin’s connected device base is vastly larger, with the company shipping over 4 million units in Q1 2025 alone according to its recent earnings disclosures. Not all of those are temperature-capable models, but a significant share of recent watches include the necessary sensors. Natural Cycles, which claims over 3 million users globally, just gained access to a much bigger funnel of potential subscribers.
The timing isn’t accidental. Demand for non-hormonal contraception has been rising steadily, driven by a combination of factors: growing consumer interest in hormone-free health management, increased awareness of fertility awareness-based methods through social media, and — in the United States specifically — a post-Dobbs environment where reproductive health decisions carry new legal weight in certain states. Natural Cycles reported a surge in downloads following the Supreme Court’s 2022 decision, and the company has continued to invest in partnerships that lower the barrier to entry.
Garmin, for its part, has been expanding its health platform beyond its traditional base of runners and outdoor athletes. The company’s recent devices include features like sleep coaching, HRV status monitoring, and menstrual cycle tracking built into Garmin Connect. Feeding temperature data into a third-party fertility algorithm is a logical extension — it makes the health sensors on Garmin watches more useful without requiring Garmin to build its own fertility prediction engine.
There are limitations. Wrist-based temperature sensing is inherently noisier than core body measurements. Skin temperature at the wrist is influenced by ambient conditions, blanket thickness, room temperature, and peripheral circulation patterns in ways that oral or vaginal sensors are not. Natural Cycles says its algorithm accounts for these variables, applying corrections and weighting overnight data appropriately. The company’s published research on wearable integrations, including peer-reviewed studies conducted with Oura Ring data, suggests that continuous wearable temperature tracking can match or exceed the accuracy of single-point oral readings for cycle prediction purposes. But independent verification of these claims specifically for Garmin wrist sensors remains limited.
Efficacy numbers also deserve scrutiny. While there still needs to be more research done for the industry as a whole, Natural Cycles’ recent peer-reviewed research data shows the company’s solution was the only method with less than a 1% mean-risk of pregnancy, with calendar-based tracking methods presenting 22-65% mean-risk and BBT-supported methods with 9%.
The competitive field is getting crowded. Clue, another popular cycle-tracking app, has been expanding its regulatory footprint. Apple’s temperature sensor in the Apple Watch Series 8 and later models provides overnight wrist temperature data that Apple uses for retrospective cycle analysis, although Apple Watch is compatible with Natural Cycles. Ava, a wrist-worn bracelet specifically designed for fertility tracking, has been in the market for years. And Tempdrop, a dedicated armband sensor, caters to the basal body temperature tracking community with a device purpose-built for the task.
What sets the Garmin–Natural Cycles pairing apart is the combination of a general-purpose consumer wearable with an FDA-cleared contraceptive algorithm. Most women who own a Garmin watch bought it for fitness tracking or smartwatch functionality, not fertility management. The integration turns an existing device into a dual-purpose tool. That’s a powerful acquisition channel for Natural Cycles and a value-add for Garmin’s hardware.
Privacy questions loom. Fertility data is among the most sensitive categories of health information, particularly in the current U.S. legal climate. Natural Cycles stores data on its own servers and says it does not sell user data to third parties. Garmin’s privacy policy governs the data within Garmin Connect. The handoff between the two platforms — temperature readings flowing from Garmin’s infrastructure to Natural Cycles’ servers — creates a data chain that users should understand before opting in. Both companies comply with GDPR in Europe; in the U.S., federal health privacy protections for consumer app data remain patchy at best, a gap that Congress has shown little urgency to close.
So where does this go? The trajectory is clear. Wearable sensors will continue to improve. Algorithms will get better at extracting signal from noisy wrist-based data. And the line between a fitness tracker and a medical device will keep blurring. The FDA has shown willingness to clear software-based health tools — Natural Cycles being a prime example — but the regulatory framework for continuously evolving algorithms fed by consumer-grade hardware is still being written in real time.
For now, the practical takeaway is straightforward. If you already wear a compatible Garmin watch and you’re interested in fertility awareness-based family planning, the integration removes a genuine daily inconvenience. If you’re considering Natural Cycles for the first time, owning a Garmin watch lowers the startup cost — you don’t need to buy a separate thermometer or an Oura Ring. And if you’re an industry observer watching the convergence of consumer wearables and digital health, this is one more data point in a trend that isn’t slowing down.
But a wristwatch is not an IUD. The technology makes fertility awareness methods more convenient. It doesn’t make them infallible. Women considering this approach should understand the efficacy data, the limitations of wrist-based temperature sensing, and their own risk tolerance — the same due diligence that applies to any contraceptive decision. The algorithm is only as good as the data it receives and the biological assumptions it encodes. A Garmin on your wrist doesn’t change that fundamental calculus. It just makes the data collection part disappear into the background, which is exactly what both companies are betting users want.
WebProNews is an iEntry Publication